GlassScriptPhysician profile
Savannah E Morgan
NPI 1922582170
$75,965.38
in general payments reported to CMS, 2019-2025
19 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $345 · 2022: $23K · 2023: $29K · 2024: $23K · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $49K · Food and Beverage: $3,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $49,152.78 |
| Food and Beverage | $3,462.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $72,381.87 | 2021-2024 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Navylist |
| Surmodics, INC. | $1,156.85 | 2022-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Merz North America, INC. | $547.98 | 2024-2025 | |
| Philips North America LLC | $324.47 | 2022-2024 | (Br5) Peripheral Ivus, (Bz1) Tack Endovascular Systems Btk |
| Veryan Medical Incorporated | $294.04 | 2021-2023 | Biomimics 3d Vascular Stent System |
| Silk Road Medical, INC. | $289.08 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Boston Scientific Corporation | $211.63 | 2021-2024 | Varithena Administration Pack, Innova Vascular |
| Cardiovascular Systems INC. | $198.95 | 2021-2023 | Diamondback Coronary |
| Medtronic, INC. | $174.43 | 2023 | Venaseal, Closurefast |
| Janssen Pharmaceuticals, INC | $136.29 | 2021-2022 | |
| Biotronik INC. | $52.29 | 2021 | |
| Abbvie INC. | $42.32 | 2024 | |
| Abbott Laboratories | $32.11 | 2023 | Diamondback Coronary, Supera |
| Endologix LLC | $26.43 | 2024 | |
| Tactile Systems Technology INC | $23.47 | 2025 | Nimbl, Flexitouch Plus |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $22.76 | 2023 | Mynx Control |
| Bard Peripheral Vascular, INC. | $22.49 | 2025 | Venovo |
| Astrazeneca Pharmaceuticals LP | $14.82 | 2022 | |
| Acera Surgical, INC. | $13.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savannah Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.